ConductScience.org, home

Paper6367451

Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial.

Lasser NL and 7 others. Am J Med, 1984. Cited by 175 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Papers, record 6367451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6367451

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial.
PubMed
Journal
Am J Med
PubMed
Year
1984
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
175
iCite
Relative citation ratio, by iCite
9.49
iCite
Revised in PubMed
2019-06-27
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lasser NLN L
2Grandits GG
3Caggiula AWA W
4Cutler JAJ A
5Grimm RH JrR H
6Kuller LHL H
7Sherwin RWR W
8Stamler JJ

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DiureticsMajor topic
HypertensionMajor topic
Adult
Blood Pressure
Body Weight
Cholesterol
Clinical Trials as Topic
Diet Therapy
Humans
Male
Middle Aged
Random Allocation
Risk
Smoking
Triglycerides

Source PubMed

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00000487Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)Background

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 175 citations.

PMIDTitleJournalYearIn PapersSource
23,105,243Effect of felodipine on the serum lipid profile of patients with hypertension.Indian J Clin Biochem2000https://conductscience.org/library/papers/23105243PubMed
22,037,772Lipid effects of antihypertensive medications.Curr Atheroscler Rep2012https://conductscience.org/library/papers/22037772PubMed
8,223,847A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.Eur J Clin Pharmacol1993https://conductscience.org/library/papers/8223847PubMed
3,914,313Combined behavioral and pharmacological treatment of essential hypertension.Biofeedback Self Regul1985https://conductscience.org/library/papers/3914313PubMed
3,884,320Diuretics. Clinical pharmacology and therapeutic use (Part II).Drugs1985https://conductscience.org/library/papers/3884320PubMed
3,720,569The drug treatment of mild hypertension in the Multiple Risk Factor Intervention Trial. A review.Drugs1986https://conductscience.org/library/papers/3720569PubMed
3,530,704The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics.Drugs1986https://conductscience.org/library/papers/3530704PubMed
3,207,551Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3207551PubMed
3,063,504Effects of diuretic drugs on the lipid profile.Drugs1988https://conductscience.org/library/papers/3063504PubMed
3,042,351Serum lipoproteins during treatment with antihypertensive drugs.Drugs1988https://conductscience.org/library/papers/3042351PubMed
2,877,846The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.Drugs1986https://conductscience.org/library/papers/2877846PubMed
2,876,554The effects of diuretics and adrenergic-blocking agents on plasma lipids.West J Med1986https://conductscience.org/library/papers/2876554PubMed
2,873,015Oslo Hypertension Study.Drugs1986https://conductscience.org/library/papers/2873015PubMed
2,518,651ACE inhibitors compared with thiazide diuretics as first-step antihypertensive therapy.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2518651PubMed
2,500,168Do antihypertensive drugs precipitate diabetes in predisposed men?BMJ1989https://conductscience.org/library/papers/2500168PubMed
2,488,113Effects of pindolol and propranolol on blood lipids in hypertensive patients.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2488113PubMed
1,810,301Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?J Gen Intern Med1991https://conductscience.org/library/papers/1810301PubMed
1,800,760The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.J Natl Med Assoc1991https://conductscience.org/library/papers/1800760PubMed
1,418,693Adverse effects of diuretics.Drug Saf1992https://conductscience.org/library/papers/1418693PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6367451

GET https://conductscience.org/api/papers/v1/6367451/authors